ProMIS Neurosciences, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

FAIR VALUE MEASUREMENTS (Tables)

FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Mar. 31, 2026

FAIR VALUE MEASUREMENTS

Summary of major categories of assets and liabilities measured at fair value on a recurring basis


		As of March 31, 2026
		Level 1			Level 2				Level 3		Total
Assets:
Short-term investments		$	33,753		$	—		$	—		$	33,753
Total assets measured at fair value		$	33,753		$	—		$	—		$	33,753
Liabilities:
Share-based compensation liability		$	—		$	—		$	79,380		$	79,380
Total liabilities measured at fair value		$	—		$	—		$	79,380		$	79,380


		As of December 31, 2025
		Level 1			Level 2				Level 3		Total
Assets:
Short-term investments		$	33,753		$	—		$	—		$	33,753
Total assets measured at fair value		$	33,753		$	—		$	—		$	33,753
Liabilities:
Share-based compensation liability		$	—		$	—		$	29,182		$	29,182
Total liabilities measured at fair value		$	—		$	—		$	29,182		$	29,182